FDA.reportPublic FDA data

Multiple apolipoprotein IVD, control

Definition
A material which is used to verify the performance of a number of assays intended to be used for the quantitative measurement of one or multiple apolipoprotein lipid analytes in a clinical specimen.
GUDID devices
7
Last updated
2026-06-04 19:44:10

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
05055273216271APOLIPOPROTEIN A1 & B LINEARITY VERIFIERS (For Roche Systems) (ApoLV-R) RANDOX LABORATORIES LIMITEDLV103572019-08-01
00816426021631K-ASSAY® Apo AI / B ControlKAMIYA BIOMEDICAL COMPANY, LLCK310C-2M2020-12-28
00816426021648K-ASSAY® Apo AI / B ControlKAMIYA BIOMEDICAL COMPANY, LLCK310C-4M2020-12-28
05055273216448APOLIPOPROTEIN A1 & B LINEARITY VERIFIERS (For Beckman Coulter AU Systems)RANDOX LABORATORIES LIMITEDLV103632020-04-17
05055273209105APOLIPOPROTEIN CONTROL - LEVEL 1 (APO CONTROL 1)RANDOX LABORATORIES LIMITEDLE50162019-06-03
05055273209112APOLIPOPROTEIN CONTROL - LEVEL 2 (APO CONTROL 2)RANDOX LABORATORIES LIMITEDLE50172019-06-03
05055273209129APOLIPOPROTEIN CONTROL - LEVEL 3 (APO CONTROL 3)RANDOX LABORATORIES LIMITEDLE50182019-06-03